{"id":"https://openalex.org/W4205100212","doi":"https://doi.org/10.1093/oncolo/oyab058","title":"Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States","display_name":"Treatment Patterns, Health Care Resource Utilization, and Cost in Patients with Myelofibrosis in the United States","publication_year":2022,"publication_date":"2022-01-05","ids":{"openalex":"https://openalex.org/W4205100212","doi":"https://doi.org/10.1093/oncolo/oyab058","pmid":"https://pubmed.ncbi.nlm.nih.gov/35274711","pmcid":"https://www.ncbi.nlm.nih.gov/pmc/articles/8914486"},"language":"en","primary_location":{"id":"doi:10.1093/oncolo/oyab058","doi":"https://doi.org/10.1093/oncolo/oyab058","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyab058","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/3/228/42828446/oyab058.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","doaj","pubmed"],"open_access":{"is_oa":true,"oa_status":"gold","oa_url":"https://academic.oup.com/oncolo/article-pdf/27/3/228/42828446/oyab058.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5032563546","display_name":"Ronda M. Copher","orcid":"https://orcid.org/0000-0001-9829-6759","observed_orcids":["https://orcid.org/0000-0001-9829-6759"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":true,"raw_author_name":"Ronda Copher","raw_affiliation_strings":["Bristol-Myers Squibb, Summit, NJ, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Summit, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5000778444","display_name":"Arianna Kee","orcid":"https://orcid.org/0000-0001-8195-0224","observed_orcids":["https://orcid.org/0000-0001-8195-0224"]},"institutions":[{"id":"https://openalex.org/I4210091812","display_name":"Bristol-Myers Squibb (United States)","ror":"https://ror.org/00gtmwv55","country_code":"US","type":"company","lineage":["https://openalex.org/I4210091812"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Arianna Kee","raw_affiliation_strings":["Bristol-Myers Squibb, Summit, NJ, USA"],"raw_orcid":"https://orcid.org/0000-0001-8195-0224","affiliations":[{"raw_affiliation_string":"Bristol-Myers Squibb, Summit, NJ, USA","institution_ids":["https://openalex.org/I4210091812"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5023728016","display_name":"Aaron Thomas Gerds","orcid":"https://orcid.org/0000-0002-3422-1309","observed_orcids":["https://orcid.org/0000-0002-3422-1309"]},"institutions":[{"id":"https://openalex.org/I1316902750","display_name":"Cleveland Clinic","ror":"https://ror.org/03xjacd83","country_code":"US","type":"healthcare","lineage":["https://openalex.org/I1316902750"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Aaron Gerds","raw_affiliation_strings":["Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Department of Hematology and Medical Oncology, Cleveland Clinic, Cleveland, OH, USA","institution_ids":["https://openalex.org/I1316902750"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":2,"corresponding_author_ids":["https://openalex.org/A5032563546"],"corresponding_institution_ids":["https://openalex.org/I4210091812"],"apc_list":{"value":3494,"currency":"USD","value_usd":3494},"apc_paid":{"value":3494,"currency":"USD","value_usd":3494},"fwci":2.2296,"has_fulltext":true,"cited_by_count":16,"citation_normalized_percentile":{"value":0.88598405,"is_in_top_1_percent":false,"is_in_top_10_percent":false},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"27","issue":"3","first_page":"228","last_page":"235"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},"topics":[{"id":"https://openalex.org/T11628","display_name":"Myeloproliferative Neoplasms: Diagnosis and Treatment","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/2720","display_name":"Hematology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T12708","display_name":"Economic and Financial Impacts of Cancer","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10804","display_name":"Health Systems, Economic Evaluations, Quality of Life","score":0.0,"subfield":{"id":"https://openalex.org/subfields/2002","display_name":"Economics and Econometrics"},"field":{"id":"https://openalex.org/fields/20","display_name":"Economics, Econometrics and Finance"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/myelofibrosis","display_name":"myelofibrosis","score":0.9990000128746033},{"id":"https://openalex.org/keywords/ruxolitinib","display_name":"ruxolitinib","score":0.9990000128746033},{"id":"https://openalex.org/keywords/treatment-patterns","display_name":"treatment patterns","score":0.8870000243186951},{"id":"https://openalex.org/keywords/healthcare-resource-utilization","display_name":"healthcare resource utilization","score":0.9980000257492065},{"id":"https://openalex.org/keywords/health-care-costs","display_name":"health care costs","score":0.8980000019073486},{"id":"https://openalex.org/keywords/suboptimal-dosing","display_name":"suboptimal dosing","score":0.718999981880188},{"id":"https://openalex.org/keywords/medication-discontinuation","display_name":"drug discontinuation","score":0.6340000033378601},{"id":"https://openalex.org/keywords/disease-burden","display_name":"disease burden","score":0.7850000262260437},{"id":"https://openalex.org/keywords/medicare-advantage","display_name":"Medicare Advantage","score":0.4909999966621399},{"id":"https://openalex.org/keywords/commercial-health-plans","display_name":"commercial health plans","score":0.6330000162124634},{"id":"https://openalex.org/keywords/inpatient-stays","display_name":"inpatient stays","score":0.6100000143051147},{"id":"https://openalex.org/keywords/pharmacy-costs","display_name":"pharmacy costs","score":0.8059999942779541}],"concepts":[{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.9065150022506714},{"id":"https://openalex.org/C2780076729","wikidata":"https://www.wikidata.org/wiki/Q1752571","display_name":"Myelofibrosis","level":3,"score":0.5890394449234009},{"id":"https://openalex.org/C2776112149","wikidata":"https://www.wikidata.org/wiki/Q7383611","display_name":"Ruxolitinib","level":4,"score":0.5206105709075928},{"id":"https://openalex.org/C2777382242","wikidata":"https://www.wikidata.org/wiki/Q6017816","display_name":"Index (typography)","level":2,"score":0.5121767520904541},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4092002809047699},{"id":"https://openalex.org/C149923435","wikidata":"https://www.wikidata.org/wiki/Q37732","display_name":"Demography","level":1,"score":0.32929527759552},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.3195266127586365},{"id":"https://openalex.org/C41008148","wikidata":"https://www.wikidata.org/wiki/Q21198","display_name":"Computer science","level":0,"score":0.0},{"id":"https://openalex.org/C2780007613","wikidata":"https://www.wikidata.org/wiki/Q546523","display_name":"Bone marrow","level":2,"score":0.0},{"id":"https://openalex.org/C144024400","wikidata":"https://www.wikidata.org/wiki/Q21201","display_name":"Sociology","level":0,"score":0.0},{"id":"https://openalex.org/C136764020","wikidata":"https://www.wikidata.org/wiki/Q466","display_name":"World Wide Web","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D003695","descriptor_name":"Delivery of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006278","descriptor_name":"Medicare","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D010342","descriptor_name":"Patient Acceptance of Health Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D012189","descriptor_name":"Retrospective Studies","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D014481","descriptor_name":"United States","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017048","descriptor_name":"Health Care Costs","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017281","descriptor_name":"Cost of Illness","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D055728","descriptor_name":"Primary Myelofibrosis","qualifier_ui":"Q000453","qualifier_name":"epidemiology","is_major_topic":true}],"locations_count":3,"locations":[{"id":"doi:10.1093/oncolo/oyab058","doi":"https://doi.org/10.1093/oncolo/oyab058","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyab058","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/3/228/42828446/oyab058.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},{"id":"pmh:oai:pubmedcentral.nih.gov:8914486","doi":null,"is_oa":true,"landing_page_url":"https://www.ncbi.nlm.nih.gov/pmc/articles/8914486","pdf_url":null,"source":{"id":"https://openalex.org/S2764455111","display_name":"PubMed Central","issn_l":null,"issn":null,"is_oa":true,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Oncologist","raw_type":"Text"},{"id":"pmid:35274711","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/35274711","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The oncologist","raw_type":"Journal Article"}],"best_oa_location":{"id":"doi:10.1093/oncolo/oyab058","doi":"https://doi.org/10.1093/oncolo/oyab058","is_oa":true,"landing_page_url":"https://doi.org/10.1093/oncolo/oyab058","pdf_url":"https://academic.oup.com/oncolo/article-pdf/27/3/228/42828446/oyab058.pdf","source":{"id":"https://openalex.org/S15523509","display_name":"The Oncologist","issn_l":"1083-7159","issn":["1083-7159","1549-490X"],"is_oa":true,"is_in_doaj":true,"is_core":true,"listed_in":["cwts-core","doaj","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","oarl","poland-140","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310316295","host_organization_name":"AlphaMed Press","host_organization_lineage":["https://openalex.org/P4310316295"],"host_organization_lineage_names":["AlphaMed Press"],"type":"journal"},"license":"cc-by","license_id":"https://openalex.org/licenses/cc-by","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"The Oncologist","raw_type":"journal-article"},"sustainable_development_goals":[{"score":0.9922999739646912,"display_name":"Good health and well-being","id":"https://metadata.un.org/sdg/3"}],"study_designs":[{"display_name":"Observational Study","id":"https://openalex.org/study-designs/observational-study"}],"awards":[],"funders":[{"id":"https://openalex.org/F4320307115","display_name":"Bristol-Myers Squibb","ror":"https://ror.org/00gtmwv55"}],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W4205100212.pdf","grobid_xml":"https://content.openalex.org/works/W4205100212.grobid-xml"},"referenced_works_count":31,"referenced_works":["https://openalex.org/W2021443159","https://openalex.org/W2086420219","https://openalex.org/W2093724620","https://openalex.org/W2115351357","https://openalex.org/W2121743767","https://openalex.org/W2126532431","https://openalex.org/W2139011653","https://openalex.org/W2144806169","https://openalex.org/W2294536664","https://openalex.org/W2511586498","https://openalex.org/W2562839751","https://openalex.org/W2606755940","https://openalex.org/W2759277150","https://openalex.org/W2771403719","https://openalex.org/W2780688021","https://openalex.org/W2783739433","https://openalex.org/W2885542040","https://openalex.org/W2890617785","https://openalex.org/W2901078409","https://openalex.org/W2957077159","https://openalex.org/W2983320382","https://openalex.org/W2996087467","https://openalex.org/W3004714210","https://openalex.org/W3006701225","https://openalex.org/W3010774459","https://openalex.org/W3012454590","https://openalex.org/W3030489735","https://openalex.org/W3030840893","https://openalex.org/W3045198911","https://openalex.org/W3105658552","https://openalex.org/W3128000097"],"related_works":["https://openalex.org/W2983320382","https://openalex.org/W4379966869","https://openalex.org/W4408310528","https://openalex.org/W2288633273","https://openalex.org/W7131679300","https://openalex.org/W3030840893","https://openalex.org/W7214056349","https://openalex.org/W4200222349","https://openalex.org/W4206459856","https://openalex.org/W4417016610"],"abstract_inverted_index":{"BACKGROUND:":[0],"This":[1],"study":[2],"analyses":[3],"treatment":[4],"patterns,":[5,29],"health":[6,52],"care":[7],"resource":[8],"utilization":[9],"(HCRU),":[10],"and":[11,18,31,34,76,105,135,172,213,222,240,251,281],"costs":[12,35],"in":[13,38,45,54,95,112,259],"patients":[14,96,152,165,179,229,260,287],"with":[15,22,40,42,98,153,231,262,285,290],"myelofibrosis":[16],"(MF)":[17],"a":[19,46,89,252,278],"subgroup":[20,90,227],"treated":[21,97,230,261],"ruxolitinib":[23],"(RUX).":[24],"MATERIALS":[25],"AND":[26],"METHODS:":[27],"Treatment":[28],"all-cause":[30],"MF-related":[32,214],"HCRU,":[33],"were":[36,93,170,174,257],"analyzed":[37,94],"adults":[39],"MF":[41,74,155,198,286],"continuous":[43],"enrollment":[44],"commercial":[47],"or":[48,72],"the":[49,55,60,66,77,85,113,119,125,136,145,196,226,294],"Medicare":[50],"Advantage":[51],"plan":[53],"pre-index":[56,114,204],"period,":[57,79,116,139],"defined":[58,80,117,140],"as":[59,81,118,141],"12":[61],"months":[62,83,121,143],"immediately":[63,122],"prior":[64,123],"to":[65,124,205,211,216],"index":[67,86,126,146],"date":[68,128,130],"(date":[69],"of":[70,164,178,183,186,244,249,255],"primary":[71],"secondary":[73],"diagnosis),":[75],"post-index":[78,137,197,207],"\u22656":[82,142],"following":[84,144],"date.":[87,148],"In":[88,225],"analysis,":[91,228],"outcomes":[92],"optimal":[99],"RUX":[100,107,115,127,133,138,147,232,264,270,291],"(OPT":[101],"RUX,":[102,109],"\u226530":[103],"mg)":[104,111],"suboptimal":[106],"(SUB":[108],"<30":[110],"3":[120],"(first":[129],"for":[131,296,300],"an":[132,154],"claim),":[134],"RESULTS:":[149],"Of":[150],"2830":[151],"diagnosis,":[156],"1191":[157],"met":[158],"eligibility":[159],"requirements.":[160],"The":[161],"median":[162],"age":[163],"was":[166],"72":[167],"years,":[168],"54%":[169],"male,":[171],"comorbidities":[173],"frequent.":[175],"Sixty":[176],"percent":[177],"received":[180],"\u22651":[181],"line":[182],"therapy":[184,250],"(LOT),":[185],"which":[187],"46%":[188],"(n":[189,233,265,271],"=":[190,234,266,272],"331)":[191],"had":[192],"\u22652":[193],"LOTs":[194],"during":[195],"period.":[199],"Costs":[200],"increased":[201],"considerably":[202],"6-month":[203,206],"(all-cause:":[208],"cause":[209],"($24,216":[210],"$48,966)":[212],"($16,502":[215],"$39,383),":[217],"driven":[218],"by":[219],"inpatient":[220],"stays":[221],"pharmacy":[223],"costs.":[224],"495)":[235],"experienced":[236],"significant":[237,279],"disease":[238,280],"burden":[239],"high":[241],"costs,":[242],"regardless":[243],"dose.":[245],"A":[246],"shorter":[247],"duration":[248],"higher":[253],"rate":[254],"discontinuation":[256],"observed":[258],"SUB":[263],"191)":[267],"versus":[268],"OPT":[269],"304).":[273],"CONCLUSION:":[274],"These":[275],"findings":[276],"suggest":[277],"economic":[282],"impacts":[283],"associated":[284],"that":[288],"persists":[289],"therapy,":[292],"highlighting":[293],"need":[295],"additional":[297],"therapeutic":[298],"options":[299],"MF.":[301]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":6},{"year":2023,"cited_by_count":4},{"year":2022,"cited_by_count":1}],"updated_date":"2026-11-04T10:54:05.112534","created_date":"2022-01-25T00:00:00"}